Week

PEPSI® Zero Sugar Teams Up With De'Von Achane to Invite 'Rookie' Cruisers Aboard a Fan Giveaway - Now Open

Retrieved on: 
Wednesday, January 31, 2024
CMO, History, Athlete, Part, Sugar, Pepsi Zero Sugar, Week, NFL, Tourism

PURCHASE, N.Y., Jan. 31, 2024 /PRNewswire/ -- De'Von Achane, a finalist for the Pepsi® Zero Sugar Rookie of the Year award, joins forces with NFL players Will Anderson Jr. and Quentin Johnston along with Pepsi® Zero Sugar to launch the third annual "Board a Rookie. Return a Pro." campaign. This year, the dynamic trio of first-year NFL stars are inviting rookie cruisers to score an unforgettable vacation getaway. Fans can enter for a chance to sail for the first time and become pro Carnival cruisers.

Key Points: 
  • This year, the dynamic trio of first-year NFL stars are inviting rookie cruisers to score an unforgettable vacation getaway.
  • De'Von Achane is teaming up with Will Anderson Jr. and Quentin Johnson, rookie cruisers themselves who both recently picked up some pro-cruiser tips.
  • PEPSI® is the Official Soft Drink Partner of the NFL and is in its 22nd year as the presenting partner of the Pepsi® Zero Sugar NFL Rookie of the Week and Pepsi® Zero Sugar NFL Rookie of the Year award.
  • Pepsi® Zero Sugar is also the "Official Zero of the NFL" for the 2023-2024 season.

Journal of the American Academy of Dermatology Publishes ZORYVE (roflumilast) Foam, 0.3% Results for Seborrheic Dermatitis from Pivotal Phase 3 Trial

Retrieved on: 
Monday, January 29, 2024
IGA, Patient, JAAD, FAAD, MD, Manuscript, Face, Success, Dermatitis, Scalp, Quality of life, BSA, MBA, Body surface area, Food, Journal, Disease, Safety, Study, FDA, Doctor of Philosophy, Week, Pharmaceutical industry

“Despite being very common, seborrheic dermatitis has traditionally been a disease with limited treatment options.

Key Points: 
  • “Despite being very common, seborrheic dermatitis has traditionally been a disease with limited treatment options.
  • These results highlight the effectiveness and safety of roflumilast foam, a steroid-free treatment and the first novel mechanism of action approved for seb derm in two decades.
  • Roflumilast foam also demonstrated statistically significant improvement over vehicle on all secondary endpoints, including itch, scaling, and erythema (redness).
  • The most common adverse reactions (≥1%) reported, per the prescribing information, include nasopharyngitis (1.5%), nausea (1.3%), and headache (1.1%).

Ultragenyx Announces Completion of Dosing Across Stage 1 Cohorts in Pivotal Phase 1/2/3 Cyprus2+ Study Evaluating UX701 Gene Therapy for the Treatment of Wilson Disease

Retrieved on: 
Thursday, January 25, 2024
Patient, ATP7B, Stage 2, Data, Safety, Wilson's disease, Pinnacle, Week, Physician, Pharmaceutical industry

NOVATO, Calif., Jan. 25, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced that all patients have been dosed with UX701 across the three dose-escalation cohorts in Stage 1 of its pivotal Phase 1/2/3 Cyprus2+ study. The company's investigational AAV9 gene therapy is designed to deliver stable expression of the ATP7B copper transporter following a single intravenous infusion, with the goal of normalizing copper metabolism in patients with Wilson disease.

Key Points: 
  • Four of five patients enrolled in Cohort 1 had started tapering standard-of-care treatment, including two that came completely off of chelators and/or zinc therapy.
  • This study evaluating UX701 for the potential treatment of Wilson disease is designed with three stages.
  • In Stage 2, a new cohort of patients will be randomized 2:1 to receive the selected dose of UX701 or placebo.
  • After the initial 52-week study period, all patients will have long-term follow up in Stage 3.

Cytokinetics Presents New Data at CMR 2024 From FOREST-HCM, the Open Label Extension Clinical Trial of Aficamten

Retrieved on: 
Thursday, January 25, 2024
Tricuspid valve, Patient, Architecture, Fibrosis, Heart, Hemodynamics, CMR, SAN, Sudden death, Pulmonary fibrosis, LVEF, Research and development, Hypertrophic cardiomyopathy, Disease, Cytokinetics, LVOT, Research, Week, Pharmaceutical industry

SOUTH SAN FRANCISCO, Calif., Jan. 25, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced new data at CMR 2024 demonstrating favorable effects on cardiac structure, function and fibrosis related to treatment with aficamten in FOREST-HCM (Follow-up, Open-Label, Research Evaluation of Sustained Treatment with Aficamten in HCM), the open label extension clinical trial of aficamten in patients with hypertrophic cardiomyopathy (HCM).

Key Points: 
  • SOUTH SAN FRANCISCO, Calif., Jan. 25, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced new data at CMR 2024 demonstrating favorable effects on cardiac structure, function and fibrosis related to treatment with aficamten in FOREST-HCM (Follow-up, Open-Label, Research Evaluation of Sustained Treatment with Aficamten in HCM), the open label extension clinical trial of aficamten in patients with hypertrophic cardiomyopathy (HCM).
  • At the time of this analysis, 16 patients in FOREST-HCM had completed a CMR at baseline and at Week 48.
  • Baseline characteristics of the CMR cohort were comparable to the overall patient population in FOREST-HCM.
  • We look forward to expanding on these data in the future.”

AEON Biopharma Presents Positive Clinical and Pre-clinical Data for ABP-450 (prabotulinumtoxinA) in Treating Cervical Dystonia and PTSD, Respectively, at a Leading Neurotoxin Conference

Retrieved on: 
Thursday, January 18, 2024
AEON, Clavicle, Patient, Heart rate, Research, PTSD, Post-traumatic stress disorder, AB toxin, Stellate ganglion, OLE, Neck, DSM-IV codes, Torticollis, Safety, INA, DBP, Head, Botulinum toxin, Lidocaine, IND, Ptosis, FDA, Toxicity, Rat, SGB, Acute stress disorder, Data, Week, Anatomy, Pharmaceutical industry

IRVINE, Calif., Jan. 18, 2024 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON, AEON WS), a clinical-stage biopharmaceutical company focused on developing a proprietary botulinum toxin complex for the treatment of multiple debilitating medical conditions, today presented new clinical and pre-clinical data for ABP-450 in treating cervical dystonia (CD) and posttraumatic stress disorder (PTSD) at TOXINS 2024, a leading conference held by the International Neurotoxin Association (INA) from January 17th - 20th at the Estrel Berlin in Berlin, Germany.

Key Points: 
  • ABP-450 did not appear to increase treatment-related TEAEs at any dose in the study.
  • These results support further investigation of ABP-450 as a treatment option for patients with CD and other movement disorders.
  • “We are excited to announce positive data from the 52-week OLE portion of the Phase 2 study of ABP-450 for CD.
  • The posters presented by AEON at the TOXINS 2024 conference can be accessed on the Events and Presentations page of the Company’s corporate website.

The Dairy Alliance Continues to Show Milk's Got Game

Retrieved on: 
Thursday, January 25, 2024
GOT, Farmer, Partnership, Athlete, University, Shooting guard, Carbohydrate, Parent, McDonald's, Week, Dairy

LOUISVILLE, Ky., Jan. 25, 2024 /PRNewswire/ -- The Dairy Alliance, a leader in raising awareness about the nutritional advantages of dairy milk, is hooping it up with Kentucky Mr. Basketball star Reed Sheppard. The nonprofit organization has joined forces with Sheppard, the accomplished Shooting Guard of the University of Kentucky men's basketball team, to showcase Milk's Got Game! This partnership represents a significant stride in The Dairy Alliance's initiatives, bringing attention to the numerous advantages of dairy milk, including its energy-boosting benefits, high-quality protein, and its role in muscle-building for athletes.

Key Points: 
  • Reed's relationships with local farmers speaks to his homegrown nature and champions the same support as The Dairy Alliance for its farmers.
  • "Reed is a standout athlete, and we are thrilled to collaborate with and share the importance and benefits of fueling up on dairy milk," said Geri Berdak , Chief Executive Officer at The Dairy Alliance.
  • "I look forward to leading this campaign that highlights the value of supporting our Kentucky dairy farmers and enjoying the nutritious benefits of dairy milk."
  • For more information about The Dairy Alliance, visit https://thedairyalliance.com or follow them on Facebook or Instagram @TheDairyAlliance.

Greenberg Traurig's Mathew S. Rosengart Named LA Daily Journal Leading Commercial Litigator

Retrieved on: 
Thursday, January 25, 2024
Corporate America, MVP, The National Law Journal, LOS, Trinity College, Daily Journal, LLP, Los, Lawyer, ABC, Commercial, Rosengart, Sport, Legalease Ltd., NLRB, NPR, Law society, The American Lawyer, Golden State, Week, Film industry

LOS ANGELES, Jan. 24, 2024 /PRNewswire-PRWeb/ -- Mathew S. Rosengart, a shareholder at global law firm Greenberg Traurig, LLP, was named a "Leading Commercial Litigator" by the Daily Journal. The second annual award honors the best commercial and bet-the-company litigators across the country, according to the publication.

Key Points: 
  • Mathew S. Rosengart, a shareholder at global law firm Greenberg Traurig, LLP, was named a "Leading Commercial Litigator" by the Daily Journal.
  • LOS ANGELES, Jan. 24, 2024 /PRNewswire-PRWeb/ -- Mathew S. Rosengart , a shareholder at global law firm Greenberg Traurig, LLP, was named a "Leading Commercial Litigator" by the Daily Journal.
  • The second annual award honors the best commercial and bet-the-company litigators across the country, according to the publication.
  • Rosengart has been previously recognized by the Daily Journal as a California Lawyer Attorney of the Year and one of the top 100 lawyers in the Golden State.

TODAY: New School Choice Possibilities Become Personal as National School Choice Week Spurs Families to Action

Retrieved on: 
Monday, January 22, 2024
National School Choice Week, Multimedia, School, Imagination, Organization, Parent, Education, National school, Week, Tutoring

MIAMI, Jan. 22, 2024 /PRNewswire/ -- A majority of U.S. parents (57 percent) say they will look for a new school for one of their children in 2024, and families thinking about making a change have a huge opportunity this month. Today starts National School Choice Week, featuring 27,112 events and activities across the country, including large-scale school fairs and community events.

Key Points: 
  • Today starts National School Choice Week, featuring 27,112 events and activities across the country, including large-scale school fairs and community events.
  • With the stage set, National School Choice Week is poised to be the catalyst that helps parents turn new education options into education solutions for their children," said Shelby Doyle, vice president of public awareness at the National School Choice Awareness Foundation.
  • NSCW, which is nonpartisan and nonpolitical, is organized by the National School Choice Awareness Foundation (NSCAF), a 501(c)(3) nonprofit organization.
  • NSCAF organizes high-impact charitable programs, including National School Choice Week and Conoce tus Opciones Escolares, in collaboration with Navigate­–the National School Choice Resource Center, which is also a 501(c)(3) nonprofit.

Prince George School Fair's on a Mission to Help Families Find, Evaluate, and Choose Great Schools

Retrieved on: 
Saturday, January 20, 2024
Student, National School Choice Week, STEM, Multimedia, School, Bishop McNamara High School, Bishop, Computer simulation, PRINCE, Robotics, Organization, Parent, Private school, Education, National school, Week, Tutoring

PRINCE GEORGE COUNTY, Md., Jan. 20, 2024 /PRNewswire/ -- A school fair highlighting local public, private, and extracurricular learning options returns to Prince George County this Sunday, Jan. 28. Join Prince George families for a day of kid-friendly fun, parent workshops, and free food. 

Key Points: 
  • Join Prince George families for a day of kid-friendly fun, parent workshops, and free food.
  • Hosted by Prince George Parents Alliance for Educational Options and the Black Student Fund, the free school fair will take place 2-5 p.m. at Bishop McNamara High School and feature booths from more than 40 local school options.
  • Workshops will engage parents and guardians on subjects such as "Paying for Independent School Education" while children enjoy a DJ, face painting, and additional fun.
  • "This in person and virtual event will provide Maryland families with information that makes school choice a reality," said Leroy Nesbitt of the Black Student Fund.

Houston School Fair at Minute Maid Park To Bring Learning Options, Free Fun to Families

Retrieved on: 
Friday, January 19, 2024
School, Music, National School Choice Week, Multimedia, Infinite, Success, RSVP, K-12, Houston Astros, Orbit, Organization, Parent, Smell, Education, National school, Week, Atmosphere

HOUSTON, Jan. 19, 2024 /PRNewswire/ -- Join the fun at the Minute Maid Park next weekend, where the annual Houston School Fair will fill the air with music, balloons, and the smell of fresh popcorn.

Key Points: 
  • HOUSTON, Jan. 19, 2024 /PRNewswire/ -- Join the fun at the Minute Maid Park next weekend, where the annual Houston School Fair will fill the air with music, balloons, and the smell of fresh popcorn.
  • This free community event will take place 10 a.m. to 1 p.m. on Saturday, Jan. 27 at the Minute Maid Park's Union Station Lobby and Atrium.
  • The Houston school fair is the largest celebration in Texas during the history-making celebration of National School Choice Week (Jan. 21-27, 2024).
  • Additional large-scale events in the Lone Star State include a school fair in Austin and a School Discovery Day in San Antonio.